XML 76 R67.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Segments - Schedule of Revenues by Major Products and Activities (Detail) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021
Product Information [Line Items] |  |  |  |
Revenues | $ 3,595 | $ 3,887 | $ 11,041 | $ 11,778
North America [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 1,809 | 1,875 | 5,450 | 5,807
Europe [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 1,069 | 1,220 | 3,396 | 3,618
International Markets [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 475 | 530 | 1,422 | 1,505
Generic products [Member] | North America [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 806 | 859 | 2,731 | 2,864
Generic products [Member] | Europe [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 803 | 895 | 2,552 | 2,637
Generic products [Member] | International Markets [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 393 | 412 | 1,175 | 1,211
COPAXONE [Member] | North America [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 105 | 133 | 285 | 448
COPAXONE [Member] | Europe [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 63 | 95 | 207 | 296
COPAXONE [Member] | International Markets [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 9 | 10 | 29 | 29
BENDEKA and TREANDA [Member] | North America [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 77 | 95 | 241 | 292
AJOVY [Member] | North America [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 57 | 46 | 142 | 123
AJOVY [Member] | Europe [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 30 | 23 | 90 | 58
AJOVY [Member] | International Markets [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 6 | 39 | 22 | 46
AUSTEDO [Member] | North America [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 260 | 201 | 618 | 520
Respiratory Product [Member] | Europe [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 62 | 85 | 198 | 263
Anda [Member] | North America [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 371 | 363 | 1,021 | 968
Other [Member] | North America [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 133 | 178 | 411 | 592
Other [Member] | Europe [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | 111 | 122 | 349 | 364
Other [Member] | International Markets [Member] |  |  |  |
Product Information [Line Items] |  |  |  |
Revenues | $ 67 | $ 69 | $ 195 | $ 219

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ProductInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=teva_NorthAmericaSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=teva_EuropeSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=teva_InternationalMarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_GenericsMediciansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_COPAXONEMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_BendekaAndTreandaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_AjovyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_AustedoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_RespiratoryProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_AndaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_OtherProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |